Methodology Consultation Success Story: Dr. Marcus Bachhuber
Between 1999 and 2015, the annual sales of opioid analgesics in the US quadrupled to about $8 billion dollars. In an effort to address over-prescribing of opioid analgesics, Dr. Marcus Bachhuber recently received a career development award (K-award) from the National Institute on Drug Abuse (NIDA) to implement a default opioid prescribing system in the electronic health […]
CHERISH Hosts Introduction to Economic Evaluation Training in March
On March 19, researchers from institutions across the country joined CHERISH leaders Bruce Schackman, Kathryn McCollister, Benjamin Linas and Sean Murphy for a daylong CHERISH introductory training to economic evaluations. Dr. Schackman began the day by introducing CHERISH to the attendees, who represented more than 25 institutions across New England, the Midwest, the Mid-Atlantic, the South […]
Two New Publications Address Expanding Access to HCV Care Among People Who Inject Drugs
Hepatitis C Virus (HCV) is one of the leading causes of infectious disease deaths in the United States. Injection drug use is a common route of HCV transmission and the annual number of reported cases continues to rise due to the opioid epidemic. Previous HCV treatment regimens had severe side effects and limited efficacy, but […]
Medications for Opioid Use Disorder: Who is Receiving Which Treatment?
In response to the growing opioid epidemic in the United States, there is an increased focus on expanding evidence-based treatment using medications prescribed for substance use disorder, especially medications that can be prescribed in outpatient settings including buprenorphine and naltrexone. The Surgeon General’s report on facing addiction in America describes substance use disorders as chronic illnesses requiring […]
CHERISH Conference on Substance Use Disorder Treatment Research
In the opening plenary panel of the CHERISH (Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV) conference on evidence-based policy and practice are (l to r) Daniel Polsky, PhD, moderator and Executive Director of the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI); Tom McLellan, PhD, Chairman of the Board and […]
New York State HepC Summit Calls for Elimination
Public health officials, elected leaders and medical professionals across New York State gathered in Albany, New York on February 7, 2017 to discuss hepatitis C in the state for the first ever New York State hepatitis C virus (HCV) summit. In a consensus statement, the committee that organized the summit called on Governor Andrew Cuomo to […]
New Medicare Payment Option for Behavioral Health Integration
Medicare rang in the new year with four new codes to reimburse primary care teams for behavioral health services. According to an article that appeared in the New England Journal of Medicine on February 2, 2017, three of the codes support services using the Collaborative Care Model (CoCM) and the fourth allows for services provided under other […]
CHERISH Profiled at the Liver Meeting® 2016
The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH) was profiled at the Liver Meeting® 2016 in Boston, MA. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and […]
Second Panel on Cost-Effectiveness in Health and Medicine
The US Panel on Cost-Effectiveness in Health and Medicine issued a report in 1996 that set the standards for reporting of cost-effectiveness studies in the field, resulting in a rapid expansion of publications and establishment of similar national standards in other jurisdictions. Twenty years later, the Second Panel on Cost-Effectiveness in Health and Medicine has […]
Medicaid’s Most Costly Outpatient Drugs include Opioids, Opioid Agonists, and HCV and HIV Treatments
The Kaiser Commission on Medicaid and the Uninsured recently released an issue brief detailing the most costly outpatient drugs to Medicaid in 2014 and the first half of 2015. Using data from the Center for Medicare and Medicaid Services (CMS), the authors analyzed outpatient drug costs based on Medicaid spending (before rebates) to determine which drugs account […]
A Computer Tool to Address Epidemic of Opioid Overdose Deaths
Pennsylvania Governor Tom Wolf on Thursday announced the launch of a new Prescription Drug Monitoring Program (PDMP) designed to log and analyze every prescription for opioids and other controlled substances dispensed anywhere in the state. The new web-based computer program is Pennsylvania’s latest tool in the battle to lower the body count of prescription drug […]
How bad is opioid misuse? Most of us think it’s really bad
As overdose deaths soar, the opioid epidemic has captured the attention of the White House, Congress, and the public. In a recent survey, about 44% of people say that they personally know someone who has been addicted to prescription painkillers. Increasingly, we see addiction as a health problem rather than as a problem to be solved […]
Engage with CHERISH
Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.